DUSA Pharmaceuticals, Inc. To Present At CIBC World Markets Health Care Conference in New York.Business Editors & Health/Medical Writers WILMINGTON, Mass.--(BW HealthWire)--Nov. 1, 2001 DUSA Pharmaceuticals, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on NMS See NetWare Management System. : DUSA) announced that Dr. Geoffrey Shulman, the Company's President and Chief Executive Officer, will be making a presentation to investors at the CIBC World Markets CIBC World Markets is the investment banking division of the Canadian Imperial Bank of Commerce. It helps governments, large companies, and other large institutions obtain capital and credit and is a primary dealer in U.S. Treasury securities. Health Care Conference. His presentation will take place in Le Louvre Louvre (l  `vrə), foremost French museum of art, located in Paris. The building was a royal fortress and palace built by Philip II in the late 12th cent. Room at The Plaza Hotel in New York on Tuesday, November 6th,
2001 at 8:00 a.m. EST EST electroshock therapy. EST abbr. electroshock therapy . The presentation will be web cast live and archived for replay. The audio webcast and presentation slides may be accessed at http://www.dusapharma.com DUSA Pharmaceuticals, Inc. is a biopharmaceutical company engaged primarily in the development of LEVULAN(R) Photodynamic Therapy (PDT) and Photodetection (PD) for multiple medical conditions. PDT and PD utilize light-activated compounds to induce a therapeutic or detection effect. DUSA is a world leader in topically or locally applied PDT and PD. The Company maintains offices in Wilmington, MA, Valhalla, NY and Toronto, Ontario. For further information contact: D. Geoffrey Shulman, MD, President & CEO or Shari Lovell, Director, Shareholder Services Tel: 416.363.5059 Fax 416.363.6602 or visit www.dusapharma.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion